Novartis reported $37.24B in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Amgen AMGN:US $ 18520M 865M
Astrazeneca AZN:US 22.65B 3.6B
AstraZeneca AZN:LN 22.65B 3.6B
Biogen BIIB:US $ 7915.9M 59.4M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Canopy Growth Corp WEED:CN C$ 1.74B 250.75M
Catalent CTLT:US $ 3025M 51M
Corcept Therapeutics CORT:US $ 388.22M 121.76M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Endo International Ordinary Shares ENDP:US $ 2492.79M 221.79M
Gilead Sciences GILD:US $ 12629M 2143M
Glaxosmithkline GSK:US $ 28988M 10314M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Horizon Pharma HZNP:US $ 2947.73M 147.96M
JAZZ PHA JAZZ:US $ 2500.86M 110.48M
Johnson & Johnson JNJ:US $ 60424M 555M
Lannett LCI:US $ 318.7M 15.91M
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 37.24B 8.48B
Pacira Pharmaceuticals PCRX:US $ 667.02M 199.03M
Perrigo Ordinary Shares PRGO:US $ 3935.5M 75.6M
Pfizer PFE:US $ 54420M 5273M
Phibro Animal Health PAHC:US $ 546.48M 37.87M
Prestige Brands PBH:US $ 293.27M 18M
Supernus Pharmaceuticals SUPN:US $ 568.52M 33.07M
Teva Pharmaceutical Industries TEVA:US $ 12451M 122M
Valeant Pharmaceuticals VRX:CN $ 5836M 229M
Zoetis ZTS:US $ 6837M 93M